↓ Skip to main content

Adalimumab for treating rheumatoid arthritis

Overview of attention for article published in Cochrane database of systematic reviews, July 2005
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
101 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adalimumab for treating rheumatoid arthritis
Published in
Cochrane database of systematic reviews, July 2005
DOI 10.1002/14651858.cd005113.pub2
Pubmed ID
Authors

Federico Navarro-Sarabia, Rafael Ariza-Ariza, Blanca Hernandez-Cruz, Isidro Villanueva

Abstract

Adalimumab is a fully human anti-TNFalpha monoclonal antibody. Published studies indicate that its use in patients with RA can be effective and safe.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 1 13%
Researcher 1 13%
Unknown 6 75%
Readers by discipline Count As %
Business, Management and Accounting 1 13%
Engineering 1 13%
Unknown 6 75%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2018.
All research outputs
#3,378,627
of 13,568,727 outputs
Outputs from Cochrane database of systematic reviews
#6,065
of 10,637 outputs
Outputs of similar age
#33,904
of 145,666 outputs
Outputs of similar age from Cochrane database of systematic reviews
#59
of 105 outputs
Altmetric has tracked 13,568,727 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 10,637 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 145,666 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 105 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.